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he aim of this in vitro study was to determine the maximum inhibitory dilution (MID) of four cetylpyridinium chloride (CPC)-
based mouthwashes: CPC+Propolis, CPC+Malva, CPC+Eucaliptol+Juá+Romã+Propolis (Natural Honey®) and CPC (Cepacol®),
against 28 Staphylococcus aureus field strains, using the agar dilution method. Decimal dilutions ranging from 1/10 to 1/
655,360 were prepared and added to Mueller Hinton Agar. Strains were inoculated using Steers multipoint inoculator. The
inocula were seeded onto the surface of the culture medium in Petri dishes containing different dilutions of the mouthwashes.
The dishes were incubated at 37ºC for 24 h. For readings, the MID was considered as the maximum dilution of mouthwash still
capable of inhibiting microbial growth. The obtained data showed that CPC+Propolis had antimicrobial activity against 27
strains at 1/320 dilution and against all 28 strains at 1/160 dilution, CPC+Malva inhibited the growth of all 28 strains at 1/320
dilution, CPC+Eucaliptol+Juá+Romã+Propolis inhibited the growth of 2 strains at 1/640 dilution and all 28 strains at 1/320
dilution, and Cepacol® showed antimicrobial activity against 3 strains at 1/320 dilution and against all 28 strains at 1/160
dilution. Data were submitted to Kruskal-Wallis test, showing that the MID of Cepacol® was lower than that determined for the
other products (p<0.05). In conclusion, CPC-mouthwashes showed antimicrobial activity against S. aureus and the addition of
other substances to CPC improved its antimicrobial effect.
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INTRODUCTION
Currently, a wide range of options in oral antiseptics and
toothpastes is available in the market. These products
contain synthetic and/or natural compounds with
antimicrobial activity12.
Among these synthetic compounds is cetylpyridinium
chloride (CPC), a quaternary ammonium compound included
in the group of the cationic surface-active agents18. It acts
primarily by penetrating the cell membrane, causing leakage
of cell components, disruption of the bacterial metabolism,
inhibition of cell growth, and finally, cell death3.
Natural extracts, such as propolis, Malva sylvestris,
Punica granatum, Zizyphus joazeiro, Eucalyptus globulus,
and Salvadora persica are included in the formulation of
commercially available oral hygiene products. The addition
of these substances aims to improve the antibacterial action,
since these natural extracts have demonstrated effect against
a wide range of microorganisms23. The antibacterial action
of CPC-based mouthwashes is variable and depends on the
product’s formulation10.
Staphylococcus aureus is a major human pathogen,
responsible for a number of hospital-acquired infections17.
This microorganism is able to colonize several locations in
the human body, but mouth, hands, and nasopharynges are
the main reservoirs for propagation of this germ in the
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hospital environment15. Therefore, control of S. aureus is
extremely relevant for the determination of the antiseptic
properties of hygiene products. The increased occurrence
of methicillin-resistant S. aureus strains (MRSA), as well as
of other strains resistant to different broad-spectrum
antimicrobial agents, represents a therapeutic challenging
situation5. Among the microorganisms present in the oral
cavity, the reduction in the number of S. aureus prior to
surgical procedures has been associated with a lower
incidence of infective endocarditis and postoperative
infections1.
The purpose of this in vitro study was to determine the
maximum inhibitory dilution (MID) of CPC-based
mouthwashes and other products containing natural extracts
in addition to CPC against 28 S. aureus field strains.
MATERIAL AND METHODS
The following CPC-based products were evaluated:
Cepacol® (Aventis Pharma Ltda., São Paulo, SP, Brazil),
Natural Honey CPC + Propolis (Skill Brothers Indústria e
Comércio Ltda, São Paulo, SP, Brazil), Natural Honey CPC
+ Malva (Skill Brothers Indústria e Comércio Ltda.), and
Natural Honey CPC+Eucaliptol+Juá+Romã+Propolis
(Skill Brothers Indústria e Comércio Ltda.) (Table 1).
MID determination was performed in duplicate by double
serial dilution (from 1/10 through 1/655,360) in test tubes
(20x200 mm) with 2.0 mL of sterile distilled water. After
dilutions, 18.0 mL of Mueller Hinton Agar culture medium
(Difco®, USA) were added to each tube, and the resulting
solutions were poured onto Petri dishes (20x100 mm).
The microbial inoculum (~108 cfu/mL) with turbidity
equivalent to a #0.5 McFarland standard was prepared in
test tubes (15x125 mm) with saline, using 28 S. aureus field
strains obtained from nasal and oral cavities. The strains
were conserved on a collection cultured on Ni agar medium.
The identification of S. aureus was based on the production
of catalase and coagulase. Regardless of the results of the
coagulase test, all catalase positive Gram-positive cocci were
submitted to the API-Staph system (bioMérieux, France)
for biochemical identification.
Microorganisms were seeded using a Steers multipoint
inoculator27. The Steers inoculator consists of two metallic
plates. One plate has 25 wells onto which 200 µL of each
standardized microbial inoculum were transferred. The other
Antiseptic
Cepacol®
Natural Honey
CPC+Propolis
Natural Honey
CPC+Malva
Natural Honey
CPC + Eucaliptol + Juá +
Romã + Propolis
Composition
- Cetylpyridinium chloride
- Disodium EDTA
- Sodium saccharin
- Polysorbate 80
- Glycerin
- Water
-Sodium phosphate monobasic
anhydrous
-Natural propolis extract
- Sodium fluoride 0.05% (226ppmF)
- Cetylpyridinium chloride (CPC)
- Sorbitol
- Sodium phosphate monobasic
- Sodium phosphate dibasic
- Natural Malva sylvestris extract
- Sodium fluoride 0.05% (226ppmF)
- Cetylpyridinium chloride(CPC)
- Sorbitol
-Sodium phosphate monobasic
-Sodium phosphate dibasic
-Natural extracts of pomegranate,
propolis, and Zizyphus joazeiro
-Eucalyptol
-Methyl salicilate
-Sodium fluoride 0.05% (226ppmF)
-Cetylpyridinium chloride(CPC)
-Sorbitol
- Eucalyptol
- Menthol
- Methyl salicilate
- Mint oil
- Chinese cinnamon flavor
- Yellow tartrazine
- Ethyl alcohol 96GL
- Ethanol
- Sorbitan monolaurate
- Sodium saccharin
- CI42.053 green
- Mint flavor
- Demineralized water
- Ethanol
- Sorbitan monolaurate
- Sodium saccharin
- CI42.090 blue
- Mint flavor
- Demineralized water
- Sodium phosphate dibasic
- Ethanol
- Sorbitan monolaurate
- Sodium saccharin
- CI 19.140 and 15.985 color
- Pomegranate flavor
- Demineralized water
TABLE 1- Chemical composition of the antiseptic solutions evaluated
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plate has 25 metallic needles that fit into the wells. Using
these needles, the inocula were seeded onto the surface of
the culture medium in Petri dishes containing different
dilutions of the mouthwashes. Since the Steers inoculator
has 25 wells and 28 strains were evaluated, three inocula (5
µL) were seeded equidistantly from each other,
approximately 1 cm from dish periphery, using an automatic
pipette.
The dishes were then incubated overnight at 37°C and
readings were performed considering the MID as the
greatest dilution of mouthwash capable of inhibiting the
growth of all test strains, following the methodology
proposed by Roberts and Addy21.
Statistical Analysis
Results were expressed as scores determined from
minimum to maximum dilution. Comparisons among the
groups were performed by Friedman’s nonparametric test.
When this test indicated significant difference between the
groups, Dunn’s multiple-comparison test, which allows two-
by-two comparison between groups, was applied.
Significance level was set at 5%.
RESULTS
The mouthwashes evaluated in this study presented
different MIDs (Table 2 and Figure 2).
Statistical analysis demonstrated no statistically
significant differences (p>0.05) among CPC+Propolis,
CPC+Malva, and CPC+Eucaliptol+Juá+Romã+Propolis.
However, the MID for Cepacol® was lower than that
determined for all other three products (p<0.05).
DISCUSSION
CPC is a cationic compound used in oral antiseptics. It
has a broad action against bacteria present in the oral
cavity21. Over 99% of the microorganisms associated with
biofilm/dental plaque formation and gingivitis are eliminated
by solutions containing 0.065% CPC30. A reduction of 39%
in biofilm/dental plaque formation has been observed in
brushed surfaces, while this percentage is 25% in non-
brushed surfaces6,9. Roberts and Addy22 (1981) reported a
residual effect for 180 to 300 min following the use of CPC-
CPC+Propolis CPC+Malva CPC+Eucaliptol+Juá+ CPC*
Romã+Propolis
i. s. i. s. c. d. c. d. i. s. i. s. c. d. c. d. i. s. i. s. c. d. c. d. i. s. i. s. c. d. c. d.
Dilution N % N % N % N % N % N % N % N %
1/640 0 0.0 0 0.0 0 0.0 0 0.0 2 7.1 2 7.1 0 0.0 0 0.0
1/320 27 96.4 27 96.4 28 100.0 28 100.0 26 92.9 28 100.0 3 10.7 3 10.7
1/160 1 3.6 28 100.0 25 89.3 28 100.0
TABLE 2- Percentage of S. aureus strains inhibited (from a total of 28 strains) by each dilution of the tested mouthwashes
* (p<0.05)
i.s. Inhibited strains
c.d. Cumulative data
FIGURE 1- Graph depicting the MID values obtained for each mouthwash
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based oral products.
Mouthwashes containing 0.05% CPC promote reduction
in the amount of salivary microorganisms for 3 h following
use21. One-minute rinsing with 15.0 mL of CPC-based
mouthwash (0.05% CPC) for two weeks resulted in an
inhibition of biofilm/dental plaque formation when associated
with mechanical cleaning24. Rawlinson, et al.20 (2008)
determined the plaque inhibition properties of two
formulations of alcohol-free mouthwash with 0.1% or 0.05%
CPC. They showed that the use of both CPC mouthwashes
resulted in less plaque accumulation compared to the control
(placebo).
According to the FDA Plaque Subcommittee, CPC is a
safe antimicrobial agent for prevention of biofilm formation
and gingivitis, when used in concentrations ranging from
0.05 to 0.1%8. In the present study, the products evaluated
had a CPC concentration of 0.05%.
According to Albuquerque Jr., et al.1 (2004),
mouthwashes containing CPC are capable of inhibiting S.
aureus strains in vitro at a 1/20 dilution. However, in this
study, the MID was 1/160 for CPC+Propolis and Cepacol®
and 1/320 for CPC+Malva and
CPC+Eucaliptol+Juá+Romã+Propolis.
Several natural extracts have been incorporated to the
formulation of oral antiseptics13, such as Jupinerus
communis, Urtica dioca, Achillaea millefoluim29 and
Salvadora persica14. In the present experiment, three out of
the four mouthwashes evaluated contain natural extracts.
Based on the obtained results, addition of these extracts to
CPC improved its antimicrobial action, as reported
elsewhere10.
Propolis, a substance present in two of the CPC-based
solutions evaluated in the present study, is described as a
natural antibiotic produced by bees, and has shown activity
against S. aureus26. However, Silici and Kutluca26 (2005)
reported only one-weak activity of propolis against the
Gram-negative microorganisms Escherichia coli and
Pseudomonas aeruginosa.
Malva sylvestris, found in one of the products evaluated
in the present study, has been shown to have
antiinflammatory action11, as well as antimicrobial activity
against E. coli and P. aeruginosa2. However, according to
Coelho de Souza, et al.7 (2004), extracts from aerial portions
of M. sylvestris do not demonstrate activity against S.
aureus, S. epidermidis, E. coli, Micrococcus luteus, and C.
albicans. Still according to the same study, only a slight
activity was observed against Saccharomyces cerevisiae.
Extract from the seed of Malva moschata, a plant found in
Scotland, is active against S. aureus, S. epidermidis, Proteus
mirabilis, and E. coli. Nevertheless, extracts obtained from
leaves, roots, and seeds may present different effects due
to the different concentrations of the active principle in the
solutions produced from each of these parts of the plant16.
Another natural ingredient added to one of the CPC-
based products evaluated is Zizyphus joazeiro extract, which
has shown antimicrobial activity against Gram-positive
microorganisms25.
Eucalyptus, another source of natural extract present in
one of the solutions evaluated in the present study, is a
genus comprising approximately 600 species of trees, native
from Australia. Eucalyptus globulus is the most commonly
cultivated species in subtropical and Mediterranean regions,
and its natural extract has shown effectiveness against S.
aureus, E. coli, P.aeruginosa, and C.albicans19. Eucalyptus
globulus, Eucalyptus maculata, and Eucalyptus viminalis
were able to inhibit the growth of several Gram-positive
bacteria (S. aureus, MRSA, Bacillus cereus, E. faecalis,
Alicyclobacillus acidoterrestrus and Propionibacterium
acnes) and one yeast (Trichophyton mentagrophytes). On
the other hand, these extracts showed little effectiveness
against Gram-negative bacteria (E. coli and P. putida).
Nevertheless, Eucalyptus botryoides and Eucalyptus nitens
extracts inhibited the growth of both Gram-positive and
Gram-negative microorganisms28.
Punica granatum (pomegranate) extract is another
compound reported as being active against S. aureus, P.
aeruginosa, C. albicans, C. krusei, C. parapsilosis and C.
tropicalis4.
CONCLUSIONS
According to the proposed methodology and based on
the obtained results, it may be concluded that the addition
of natural extracts to CPC enhanced its antimicrobial effect.
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